Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03182335 · ClinicalTrials.gov registry record

Vasopressor SAT Study

A clinical trial of Critical Illness and Delirium, sponsored by University of Chicago.

Active
Registry status
800
Enrollment target
1
Study location

NCT03182335 is a study of Critical Illness and Delirium that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 800 participants, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03182335, a study of Critical Illness and Delirium, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
800 participants
Enrollment target
1
Study location

Study Summary

To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation.

Interventions

  • OTHER sedation awakening trial

Study Locations (1)

Illinois

  • The University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2014-04-28
Est. Completion 2026-06

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03182335

The ClinicalTrials.gov registry entry for NCT03182335 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (74% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which sedation awakening trial is the first listed.

NCT03182335 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03182335 about?

NCT03182335 is a clinical study titled "Vasopressor SAT Study". To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation...

What is the current status of trial NCT03182335?

This trial is currently active not recruiting. The enrollment target is 800 participants. The study started on 2014-04-28. Estimated completion is 2026-06.

What conditions does trial NCT03182335 study?

This clinical trial studies the following conditions: Critical Illness, Delirium, Low Blood Pressure.

What interventions are being tested in trial NCT03182335?

The interventions under investigation include: sedation awakening trial (OTHER).

Who is sponsoring clinical trial NCT03182335?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03182335 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.